Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam Inc (NQ: BEAT )

2.780 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.780
Bid (Size) 2.710 (5)
Ask (Size) 3.100 (3)
Prev. Close 2.780
Today's Range 2.780 - 2.780
52wk Range 1.060 - 3.389
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index
Via Investor Brand Network
HeartBeam Added to Russell Microcap® Index
From HeartBeam, Inc.
Via Business Wire

Performance

YTD
+19.31%
+19.31%
1 Month
+15.83%
+15.83%
3 Month
+39.00%
+39.00%
6 Month
+71.60%
+71.60%
1 Year
-10.32%
-10.32%

More News

Read More
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BEAT Stock Earnings: HeartBeam Meets EPS for Q4 2023
Via InvestorPlace
Recap: HeartBeam Q4 Earnings
Via Benzinga
A Preview Of HeartBeam's Earnings
Via Benzinga
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) AIMIGo(TM) Recognized as ‘Best New ECG Technology Solution’ in Awards Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
BEAT Stock Earnings: HeartBeam Misses EPS for Q1 2024
Via InvestorPlace
HeartBeam Reports First Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules Conference Call to Discuss Q1 2024 Results
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
Earnings Scheduled For March 20, 2024
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
From HeartBeam, Inc.
Via Business Wire
What's Going On With Heartbeam (BEAT) Stock?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.